ARTIS Ventures Revenue and Competitors
Employee Data
- ARTIS Ventures has 36 Employees.
- ARTIS Ventures grew their employee count by 38% last year.
ARTIS Ventures's People
Name | Title | Email/Phone |
---|---|---|
1 | Managing General Partner and Founder | Reveal Email/Phone |
2 | COO | Reveal Email/Phone |
3 | DIRECTOR OF INTERNATIONAL MARKETING | Reveal Email/Phone |
4 | Director Administration | Reveal Email/Phone |
5 | Partner | Reveal Email/Phone |
6 | Fellow | Reveal Email/Phone |
ARTIS Ventures Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 18 | -5% | N/A | N/A |
#2 | N/A | 8 | 0% | N/A | N/A |
#3 | $7.5M | 57 | 10% | N/A | N/A |
#4 | N/A | 55 | 45% | N/A | N/A |
#5 | N/A | 97 | 62% | N/A | N/A |
#6 | N/A | 12 | -8% | N/A | N/A |
#7 | N/A | 9 | 13% | N/A | N/A |
#8 | $3.5M | 17 | 70% | N/A | N/A |
#9 | N/A | 9 | 29% | N/A | N/A |
#10 | $15M | 131 | 6% | N/A | N/A |
What Is ARTIS Ventures?
ARTIS Ventures (AV) partners with entrepreneurs who are driven to impact the world by reshaping and reinventing industries. The team supports its portfolio companies through their entire life-cycle, from initial venture investment to public offering and beyond. \n\nAs an early leader in the emerging TechBio sector, ARTIS Ventures funds companies at the intersection of computer science and life science, applying engineering principles and data-enabled discovery to the healthcare space. \n\nNotable companies the firm has backed include Stemcentrx, Lemonaid Health, Viacyte, Eko Health, Outpace Bio, RadAI, Delix Therapeutics, Freenome, Excision Bio, Modern Meadow, Palantir, YouTube, Cohesity, and many more. For more information visit www.av.co or email contact@av.co.
keywords:N/AN/A
Total Funding
36
Number of Employees
N/A
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 36 | 20% | $8M |
#2 | $3.8M | 36 | 13% | $29M |
#3 | $7.5M | 36 | 13% | $60.5M |
#4 | $4.2M | 36 | N/A | N/A |
#5 | $4.2M | 36 | N/A | N/A |